Skip to main content
    P

    Purple Biotech (PPBT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.68
    +0.05 (+3.07%)

    Market Cap: $2.65M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Purple Biotech (PPBT) Earnings: Report Dates and Results

    Updated Aug 7, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Jun 30, 2026, Purple Biotech reported EPS of $1.07, above the -$0.98 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    38%(10/26)
    Avg Surprise
    -20.56%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A

    Next Report

    No consensus estimate is on file yet for the quarter ending Dec 31, 2026.

    PPBT's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 27 quarters below that had an estimate, PPBT beat 10, missed 12 and matched 5. The widest gap in the table came in the quarter ended Mar 31, 2026, when EPS landed 512.45% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026$1.07-$0.98-$0.98 - -$0.98+209.18%BeatN/A10 up, 1 downAug 7, 2026N/A
    Mar 31, 2026-$2.33-$0.38-$0.38 - -$0.38-512.45%MissN/A11 up, 0 downMay 15, 2026N/A
    Dec 31, 2025-$6.16-$3.40N/A-81.18%MissN/A10 up, 0 downMar 13, 2026N/A
    Sep 30, 2025$2.90-$2.60-$2.60 - -$2.60+211.54%BeatN/A10 up, 0 downNov 14, 2025N/A
    Jun 30, 2025-$4.00-$2.10-$2.10 - -$2.10-90.48%MissN/A10 up, 0 downAug 6, 2025N/A
    Mar 31, 2025-$0.17N/AN/AN/AN/AN/AN/A0 up, 0 downMay 21, 2025N/A
    Dec 31, 2024-$2.71-$2.20-$2.20 - -$2.20-23.18%MissN/A11 up, 0 downMar 10, 2025N/A
    Sep 30, 2024-$13.67-$0.60-$0.60 - -$0.60N/AN/AN/A11 up, 0 downNov 15, 2024N/A
    Jun 30, 2024-$15.88-$26.00N/A+38.92%BeatN/A20 up, 0 downAug 16, 2024N/A
    Mar 31, 2024-$30.26-$30.00-$46.00 - -$30.00-0.87%MissN/A20 up, 0 downMay 21, 2024N/A
    Dec 31, 2023-$63.14-$34.00N/A-85.71%MissN/A30 up, 0 downMar 5, 2024N/A
    Sep 30, 2023-$42.02-$44.00-$50.00 - -$44.00+4.50%BeatN/A30 up, 0 downNov 21, 2023N/A
    Jun 30, 2023-$44.22-$50.00-$74.00 - -$50.00+11.56%BeatN/A31 up, 0 downAug 22, 2023N/A
    Mar 31, 2023-$41.60-$70.00-$74.00 - -$70.00+40.57%BeatN/A20 up, 0 downMay 16, 2023N/A
    Dec 31, 2022-$58.90-$50.00-$66.00 - -$40.00-17.80%MissN/A20 up, 0 downFeb 8, 2023N/A
    Sep 30, 2022-$45.56-$42.00N/A-8.48%MissN/AN/AN/ANov 8, 2022N/A
    Jun 30, 2022-$0.20-$0.20N/A0.00%In lineN/AN/AN/AAug 4, 2022N/A
    Mar 31, 2022-$0.41N/AN/AN/AN/AN/AN/AN/AMay 12, 2022N/A
    Dec 31, 2021-$0.25-$2.00N/A+87.50%BeatN/AN/AN/AFeb 9, 2022N/A
    Sep 30, 2021-$0.17-$0.20N/A+15.00%BeatN/AN/AN/ADec 1, 2021N/A
    Jun 30, 2021Not reported-$0.01N/AN/ANot reportedN/AN/AN/AAug 5, 2021N/A
    Mar 31, 2021-$76.00-$2.00N/AN/AN/AN/AN/AN/AJun 10, 2021N/A
    Dec 31, 2020-$0.01-$0.01N/A0.00%In lineN/AN/AN/AMar 2, 2021$500000
    Sep 30, 2020-$0.01-$0.01N/A0.00%In lineN/AN/AN/ADec 2, 2020N/A
    Jun 30, 2020-$0.01-$0.01N/A0.00%BeatN/AN/AN/AAug 11, 2020$500000
    Mar 31, 2020-$0.04N/AN/AN/AN/AN/AN/AN/AJun 3, 2020$500000
    Dec 31, 2019-$0.30-$0.09N/A-233.33%MissN/AN/AN/AFeb 11, 2020$1.00M
    Sep 30, 2019Not reported-$0.13N/AN/ANot reportedN/AN/AN/ANov 27, 2019N/A
    Jun 30, 2019Not reported-$0.60N/AN/ANot reportedN/AN/AN/AAug 8, 2019$500000
    Mar 31, 2019-$0.19-$0.19N/A0.00%In lineN/AN/AN/AMay 29, 2019$500000
    Dec 31, 2018-$30.00-$20.00N/A-50.00%MissN/AN/AN/AFeb 7, 2019$1.00M
    Sep 30, 2018Not reported-$0.01N/AN/ANot reportedN/AN/AN/ANov 28, 2018N/A
    Jun 30, 2018-$0.01-$0.01N/A0.00%BeatN/AN/AN/AAug 29, 2018$500000
    Mar 31, 2018-$0.10-$0.10N/A0.00%In lineN/AN/AN/AMay 5, 2018$500000
    Dec 31, 2017-$30.00-$20.00N/A-50.00%MissN/AN/AN/AMar 5, 2018$50000
    Dec 31, 2016Not reported-$0.25N/AN/ANot reportedN/AN/AN/AMar 17, 2017N/A
    Sep 30, 2016-$2.90N/AN/AN/AN/AN/AN/AN/ANov 30, 2016N/A
    Dec 31, 2015-$13.10-$9.70N/A-35.05%MissN/AN/AN/AMar 18, 2016N/A
    Sep 30, 2015-$19.38N/AN/AN/AN/AN/AN/AN/ANov 25, 2015N/A
    Last 39 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$7.43, after -$62.52 the year before. It was -$2.90 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$7.43N/A
    Dec 31, 2024-$62.52N/A
    Dec 31, 2023-$190.98N/A
    Dec 31, 2022-$105.07N/A
    Dec 31, 2021-$76.42N/A
    Dec 31, 2020-$0.07N/A
    Dec 31, 2019-$0.49N/A
    Dec 31, 2018-$30.11N/A
    Dec 31, 2017-$30.00N/A
    Dec 31, 2016-$2.90N/A

    Frequently Asked Questions About PPBT

    Did PPBT beat earnings estimates last quarter?

    Yes. Purple Biotech reported EPS of $1.07 for the quarter ended Jun 30, 2026, above the -$0.98 estimate, a 209.18% surprise.

    How often does PPBT beat earnings estimates?

    Purple Biotech beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -31.06%.